The results are in from drug giant Merck's most recent trial of a vaccine for Ebola — and they look pretty good:
The vaccine was 100 percent effective when it was tested on more than 4,000 people who were in close contact with Ebola patients in the African nation of Guinea, the World Health Organization said, citing a study published today in the Lancet medical journal. The trial of the vaccine, called Ebola ca suffit — "Ebola, that's enough" in French — began on March 23. [Bloomberg]
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why Bhutan hopes tourists will put a smile back on its faceUnder The Radar The 'kingdom of happiness' is facing economic problems and unprecedented emigration
-
7 beautiful towns to visit in Switzerland during the holidaysThe Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
-
The Week contest: Werewolf billPuzzles and Quizzes
-
ACA opens 2025 enrollment, enters 2024 raceSpeed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
-
McDonald's sued over E. coli linked to burgerSpeed Read The outbreak has sickened at least 49 people in 10 states and left one dead
-
Texas dairy worker gets bird flu from infected cowSpeed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
-
Dengue hits the Americas hard and earlySpeed Read Puerto Rico has declared an epidemic as dengue cases surge
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical recordsSpeed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
-
Afghanistan has a growing female suicide problemSpeed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
-
US life expectancy rose in 2022 but not to pre-pandemic levelsSpeed Read Life expectancy is slowly crawling back up
